178 related articles for article (PubMed ID: 27329321)
21. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.
Thompson K; Menzies S; Muckenthaler M; Torti FM; Wood T; Torti SV; Hentze MW; Beard J; Connor J
J Neurosci Res; 2003 Jan; 71(1):46-63. PubMed ID: 12478613
[TBL] [Abstract][Full Text] [Related]
22. Hepcidin induction limits mobilisation of splenic iron in a mouse model of secondary iron overload.
Camberlein E; Abgueguen E; Fatih N; Canonne-Hergaux F; Leroyer P; Turlin B; Ropert M; Brissot P; Loréal O
Biochim Biophys Acta; 2010 Mar; 1802(3):339-46. PubMed ID: 20045050
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
24. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
[TBL] [Abstract][Full Text] [Related]
25. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
26. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
Smith MA; Nunomura A; Zhu X; Takeda A; Perry G
Antioxid Redox Signal; 2000; 2(3):413-20. PubMed ID: 11229355
[TBL] [Abstract][Full Text] [Related]
27. Pre-treatment of rats with ad-hepcidin prevents iron-induced oxidative stress in the brain.
Gong J; Du F; Qian ZM; Luo QQ; Sheng Y; Yung WH; Xu YX; Ke Y
Free Radic Biol Med; 2016 Jan; 90():126-32. PubMed ID: 26582371
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
29. The role of hepcidin and ferroportin in iron absorption.
Oates PS
Histol Histopathol; 2007 Jul; 22(7):791-804. PubMed ID: 17455153
[TBL] [Abstract][Full Text] [Related]
30. The metal theory of Alzheimer's disease.
Bush AI
J Alzheimers Dis; 2013; 33 Suppl 1():S277-81. PubMed ID: 22635102
[TBL] [Abstract][Full Text] [Related]
31. Metal dyshomeostasis and oxidative stress in Alzheimer's disease.
Greenough MA; Camakaris J; Bush AI
Neurochem Int; 2013 Apr; 62(5):540-55. PubMed ID: 22982299
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
33. Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain.
Kuhla A; Ludwig SC; Kuhla B; Münch G; Vollmar B
Neurobiol Aging; 2015 Feb; 36(2):753-61. PubMed ID: 25448604
[TBL] [Abstract][Full Text] [Related]
34. Changes in skeletal muscle iron metabolism outpace amyotrophic lateral sclerosis onset in transgenic rats bearing the G93A hmSOD1 gene mutation.
Halon M; Kaczor JJ; Ziolkowski W; Flis DJ; Borkowska A; Popowska U; Nyka W; Wozniak M; Antosiewicz J
Free Radic Res; 2014 Nov; 48(11):1363-70. PubMed ID: 25175826
[TBL] [Abstract][Full Text] [Related]
35. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
Reddy PH
J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress and redox-active iron in Alzheimer's disease.
Honda K; Casadesus G; Petersen RB; Perry G; Smith MA
Ann N Y Acad Sci; 2004 Mar; 1012():179-82. PubMed ID: 15105265
[TBL] [Abstract][Full Text] [Related]
37. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
[TBL] [Abstract][Full Text] [Related]
38. Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation.
Crespo ÂC; Silva B; Marques L; Marcelino E; Maruta C; Costa S; Timóteo A; Vilares A; Couto FS; Faustino P; Correia AP; Verdelho A; Porto G; Guerreiro M; Herrero A; Costa C; de Mendonça A; Costa L; Martins M
Neurobiol Aging; 2014 Apr; 35(4):777-85. PubMed ID: 24199959
[TBL] [Abstract][Full Text] [Related]
39. Misdistribution of iron and oxidative stress in chronic kidney disease.
Nakanishi T; Kuragano T; Nanami M; Nagasawa Y; Hasuike Y
Free Radic Biol Med; 2019 Mar; 133():248-253. PubMed ID: 29958932
[TBL] [Abstract][Full Text] [Related]
40. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
